HIV/AIDS Clinical Trials

HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings

Condition: HIV

NCT ID: NCT01256463

Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

Condition: HIV Infections

NCT ID: NCT00273780

The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1

Condition: Adherence; HIV Risk Behaviors; Alcohol & Drug Use; Health Behaviors; Sexual Risk Behaviors

NCT ID: NCT00227825

Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention

Condition: Reduction in Heavy Drinking in Patients With HIV

NCT ID: NCT01227044

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Condition: HIV Infections

NCT ID: NCT01524900

A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]

Condition: HIV Infections

NCT ID: NCT01013935

A Medication Adherence Intervention for HIV Infected Veterans

Condition: HIV Infection

NCT ID: NCT00013065

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00203853

Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)

Condition: HIV Infections

NCT ID: NCT00643903

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00073424

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Condition: HIV

NCT ID: NCT01423812

A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Condition: HIV Infections

NCT ID: NCT00001122

Self-Managing HIV and Chronic Disease

Condition: HIV/AIDS

NCT ID: NCT01032824

Effects of Home Visits on Medication Adherence in Children and Youth With HIV

Condition: HIV Infections

NCT ID: NCT00006439

Enhancing Communication and HIV Outcomes

Condition: HIV Infections

NCT ID: NCT00675610

Stress-Reducing Interventions in HIV+ Patients: Pilot

Condition: Stress Disorders, Post-Traumatic; HIV Infections

NCT ID: NCT00599599

Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

Condition: HIV Infection

NCT ID: NCT01322932

HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users

Condition: HIV; Drug Use Disorders

NCT ID: NCT01413529

Treatment for Depression Among HIV-Infected Youth

Condition: HIV; Depression; HIV Infections

NCT ID: NCT01049789

Positive Lifestyles Using Safety

Condition: HIV; HIV Infections

NCT ID: NCT00836290

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

Condition: Acute HIV Infection; HIV Infections

NCT ID: NCT00924898

Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT01433185

Cognitive Behavioral Stress Management for HIV+ Drug Abusers

Condition: HIV/AIDS; Drug Abuse; Alcohol Abuse

NCT ID: NCT00722644

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Healthy

NCT ID: NCT00917904

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00917891

Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men

Condition: HIV Prevention; HIV Infections

NCT ID: NCT01087840

Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management

Condition: HIV

NCT ID: NCT01510340

An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV

Condition: HIV

NCT ID: NCT00611429

Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01383005

Safety Study of Once a Day ART and Opiate Substitute.

Condition: HIV Infections

NCT ID: NCT00324688

Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care

Condition: The Focus of the Study is the Treatment and Retention in Treatment for HIV+ ex Inmates.

NCT ID: NCT01406626

Integrated Treatment of Marijuana Abuse for HIV+ Youth

Condition: HIV Infections

NCT ID: NCT00683488

Home-Based AIDS Care Project

Condition: HIV Infections

NCT ID: NCT00119093

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

Understanding Medication Adherence Among HIV Patients

Condition: Patient Commitment Preferences for Medication Adherence

NCT ID: NCT01305590

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Condition: HIV Infection; AIDS

NCT ID: NCT00214435

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00032669

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Condition: HIV Infections

NCT ID: NCT00323544

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

Condition: HIV Infections

NCT ID: NCT00100568

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

Condition: HIV Infections; Pregnancy Complications, Infectious

NCT ID: NCT00028145

The First Failure Study

Condition: HIV; HIV Infections

NCT ID: NCT01118871

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Condition: HIV Infections

NCT ID: NCT00385645

Extending HIV Care Beyond the Rural Health Center

Condition: HIV; HIV Infections

NCT ID: NCT00371540

The PeerCARE Study (Peer Community-based Assistant in REtention)

Condition: HIV

NCT ID: NCT01366690

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

Condition: HIV Infections

NCT ID: NCT00224445

An Automated, Tailored Information Application for Medication Health Literacy

Condition: Human Immunodeficiency Virus I Infection

NCT ID: NCT01304186

Behavioral Depression Treatment for African American HIV-infected Substance Users

Condition: Major Depressive Disorder; Substance Use

NCT ID: NCT01351454

Treatment Options for Protease Inhibitor-exposed Children

Condition: HIV/AIDS; HIV Infections

NCT ID: NCT01146873

Cameroon Mobile Phone SMS Trial

Condition: Adherence; HIV

NCT ID: NCT01247181

Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men

Condition: Stimulant-Related Disorders; HIV; HIV Infections

NCT ID: NCT01140880

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Condition: Lymphoma, AIDS Related; HIV Infections

NCT ID: NCT00799136

Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.

Condition: HIV Infections

NCT ID: NCT01011413

A Randomized Trial of Vaccine Adherence in Young Injection Drug Users - 1

Condition: Adherence; Community Outreach; HIV Risk Behaviors; Hepatitis A Vaccines; Hepatitis B Vaccines; Hepatitis C; Needle-Exchange Programs; Substance Abuse, Intravenous

NCT ID: NCT00244374

Microbicides Acceptability Among Sexually Active Young Women

Condition: HIV Infections

NCT ID: NCT00490152

Centralized Off-Site Adherence Enhancement Program

Condition: HIV/AIDS

NCT ID: NCT01409655

A Mindfulness Based Approach to HIV Treatment Side Effects

Condition: HIV Infections

NCT ID: NCT00312936

Engaging Care for HIV-Infected Adolescent Females.

Condition: HIV Infection

NCT ID: NCT00489034

HIV Treatment-Readiness Measure (HTRM) Validation

Condition: HIV Infections

NCT ID: NCT00686049

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

Condition: HIV Disease

NCT ID: NCT01338025

Providing Voluntary HIV Counseling and Testing Plus Linkage to Care in Uganda

Condition: HIV Infections

NCT ID: NCT00648232

Directly Observed Antiretroviral Therapy Among Active Drug Users

Condition: HIV/AIDS; Substance Abuse

NCT ID: NCT00367172

The Treatment of Insomnia in Patients With HIV Disease

Condition: HIV Infections; Insomnia

NCT ID: NCT00465972

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Condition: HIV Infections; Diffuse Large B Cell Lymphoma

NCT ID: NCT00466258

Abstinence-reinforcing Contingency Management to Suppress HIV Viral Load

Condition: HIV; Opiate Dependence

NCT ID: NCT01376570

The Efficacy of the HIV/AIDS Symptom Management Manual

Condition: HIV; Acquired Immunodeficiency Syndrome

NCT ID: NCT00241202

Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age

Condition: HIV Infections

NCT ID: NCT01127204

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Condition: Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%

NCT ID: NCT00199979

Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

Condition: HIV Infections; Antiretroviral Naive

NCT ID: NCT00196599

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

Condition: HIV Infections

NCT ID: NCT00196612

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

Combination of Efavirenz and Truvada - COMET Study

Condition: HIV Infections

NCT ID: NCT00224458

Buprenorphine and Integrated HIV Care

Condition: Substance-Related Disorders; Drug Addiction; Human Immunodeficiency Virus; AIDS; HIV Infections

NCT ID: NCT00317460

A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

Condition: HIV; HIV Infections

NCT ID: NCT01042652

Use of Incentives to Retain Drug Users in HIV Therapy

Condition: HIV Infection

NCT ID: NCT01488942

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116415

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116116

Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01404312

Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1

Condition: Adherence; Behavior Therapy; Depression; Heroin Dependence; Methadone; Motivational Interviewing; Substance-Related Disorders

NCT ID: NCT00218634

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)

Condition: Antiretroviral Therapy in HIV-1 Infected Children

NCT ID: NCT01196195

Testing and Linkage to Care for Injecting Drug Users in Kenya

Condition: HIV Infection

NCT ID: NCT01557998

Bangkok Tenofovir Study

Condition: HIV Infections

NCT ID: NCT00119106

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Condition: HIV Infections

NCT ID: NCT00135382

A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi

Condition: Tuberculosis

NCT ID: NCT01356095

Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

Condition: Cardiovascular Disease; HIV Infections

NCT ID: NCT01066065

HIV and Hepatitis Care Coordination in Methadone Treatment

Condition: Hepatitis, Viral, Human; HIV Infections

NCT ID: NCT00608192

Managerial Database II

Condition: HIV

NCT ID: NCT01009827

Will Having Alcohol Treatment Improve Functioning?

Condition: HIV; Alcoholism

NCT ID: NCT01245647

A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)

Condition: HIV

NCT ID: NCT01445223

Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00497055

Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00318409

Behavioral Intervention Trial for HIV-Infected Injection Drug Users

Condition: HIV

NCT ID: NCT00146445

Pregnant Women's CoOp

Condition: HIV

NCT ID: NCT00722670

Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi

Condition: HIV

NCT ID: NCT01414413

Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection

Condition: HIV; Pregnancy

NCT ID: NCT01448512

Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border

Condition: HIV Positive

NCT ID: NCT01152684

Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS

Condition: HIV Infections

NCT ID: NCT00164385

Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects

Condition: HIV Infections; Adverse Effects

NCT ID: NCT00696839

Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS

Condition: Anxiety Disorders; HIV Infections

NCT ID: NCT00887679

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Condition: HIV Infections

NCT ID: NCT00002409

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00075907

Contingency Management in the Delivery of HAART to Drug Users in Chennai, India

Condition: HIV; Substance Abuse, Intravenous

NCT ID: NCT01031745

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

Condition: Hepatitis C; Depressive Disorder, Major; Depressive Disorder; Depression; HIV Infections

NCT ID: NCT00655226

Telephone Based Cognitive Behavioral Therapy for HIV Related Depression

Condition: Depression; HIV Infections

NCT ID: NCT01055158

Behavioral, Clinical and Basic Science Studies of Non-Occupational Post-Exposure Prophylaxis ("PEP-2")

Condition: HIV Infections

NCT ID: NCT00473018

Positive Choices Efficacy Trial

Condition: HIV; Patient Compliance

NCT ID: NCT01559805

HIV Translating Initiatives for Depression Into Effective Solutions

Condition: HIV; Depression

NCT ID: NCT00304915

Managerial Database II

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT01322217

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00993148

Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women

Condition: HIV Infections; Alcoholism

NCT ID: NCT00127231

Central Nervous System Disease in HIV-infected Children on HAART

Condition: HIV Infections; Central Nervous System Diseases

NCT ID: NCT00110331

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00071760

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries

Condition: HIV Infections

NCT ID: NCT01061151

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

Condition: HIV Infection

NCT ID: NCT00246610

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Condition: HIV Infections; AIDS-Related Opportunistic Infections

NCT ID: NCT00055120

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in Men Who Have Sex With Men

Condition: HIV Infection

NCT ID: NCT01505114

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Condition: HIV Infections

NCT ID: NCT00035932

Neurocognitive Assessment in Youth Initiating HAART

Condition: HIV Infections

NCT ID: NCT00683579

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Condition: Tuberculosis

NCT ID: NCT00330304

HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth

Condition: Acquired Immunodeficiency Syndrome; Stress Disorders, Post-Traumatic

NCT ID: NCT01401335

Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

Condition: HIV Infections

NCT ID: NCT01490671

Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa

Condition: HIV

NCT ID: NCT00341393

Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya

Condition: HIV; Malnutrition

NCT ID: NCT01548599

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)

Condition: HIV

NCT ID: NCT01253538

Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation

Condition: HIV Infections

NCT ID: NCT00872261

Buprenorphine HIV Care Integration Project

Condition: HIV Infection; Opioid-Related Disorders

NCT ID: NCT00348868

Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis

Condition: HIV Infections

NCT ID: NCT01327651

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Condition: HIV Infections

NCT ID: NCT00036452

Atripla to Raltegravir Switch Study

Condition: HIV Infection

NCT ID: NCT01195467

Kaletra and Viread in Antiretroviral Naïve Patients

Condition: HIV Infections

NCT ID: NCT00679926

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

Condition: HIV Infections

NCT ID: NCT00756730

An Electronic Pillbox for People With HIV

Condition: HIV Infections

NCT ID: NCT00071500

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Condition: HIV Infections

NCT ID: NCT00084136

Buprenorphine and Integrated HIV Care Evaluation

Condition: Opioid-Related Disorders; HIV Infections; AIDS

NCT ID: NCT00124358

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00365612

Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)

Condition: Buprenorphine; HIV; Drug Abuse; Drug Addiction; Drug Dependence; Drug Use Disorders; Drug Use Disorder; Substance Abuse; Opiate Addiction; Substance-Related Disorders

NCT ID: NCT00798538

Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)

Condition: Fetal Alcohol Syndrome; HIV; Nutrition Disorders

NCT ID: NCT00996528

Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00497081

Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania

Condition: HIV Infections

NCT ID: NCT00523510

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006154

Test of an Intervention to Improve HIV Care

Condition: HIV Infection

NCT ID: NCT01103856

Housing and Health Study

Condition: HIV; AIDS

NCT ID: NCT00153504

Raltegravir as Early Therapy in African-Americans Living With HIV Study

Condition: HIV Infections

NCT ID: NCT00667433

A Parenting and Self-Care Intervention for HIV Infected Mothers

Condition: HIV

NCT ID: NCT01586988

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT

Condition: HIV; AIDS; Kaposi's Sarcoma; Human Herpesvirus 8

NCT ID: NCT00380770

Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya

Condition: HIV; Malnutrition; HIV Infections

NCT ID: NCT00838292

Linkage to Care - Part I

Condition: HIV

NCT ID: NCT00703040

Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection

Condition: HIV Infections; Primary Acute Infection

NCT ID: NCT00196638

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00718536

HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics

Condition: Behavioral Disorders Due to Psychoactive Substance Use

NCT ID: NCT01312181

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Condition: HIV

NCT ID: NCT00335270

Safety of Raltegravir When Given as Part of HIV Therapy in HIV/HCV Coinfected Individuals

Condition: HIV/ Hepatitis C Co-Infection

NCT ID: NCT01147107

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

Condition: HIV Infection

NCT ID: NCT01473472

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00946595

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Condition: HIV Infections

NCT ID: NCT00460382

Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine

Condition: HIV Infections; Insulin Resistance; Hyperlactatemia

NCT ID: NCT00471614

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00454337

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00082498

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection With the Objective to Induce a Strong Specific HIV Immune Response Able to Control Viral Replication Without Highly Active Anti-Retroviral Therapy (HAART)

Condition: HIV

NCT ID: NCT00979706

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

Condition: Hepatitis C Virus; HIV Infections

NCT ID: NCT00496912

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

Botswana Tenofovir Oral HIV Prophylaxis Trial

Condition: HIV Infection

NCT ID: NCT00111150

The Treatment Advocacy Program

Condition: HIV

NCT ID: NCT00164333

Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125

Condition: HIV

NCT ID: NCT00792324

Botswana TDF/FTC Oral HIV Prophylaxis Trial

Condition: HIV Infections

NCT ID: NCT00448669

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00495651

Impact of Immediate Versus WHO Recommendations Guided ART Initiation on HIV Incidence - Feasibility Phase

Condition: HIV Infection

NCT ID: NCT01509508

Antiretroviral Therapy for Acute HIV Infection

Condition: Acute HIV Infection

NCT ID: NCT00796263

Effects of Contingency Management for Methamphetamine Abstinence on Post-Exposure Prophylaxis for HIV in Men Who Have Sex With Men (MSM)

Condition: Amphetamine-Related Disorders; HIV; HIV Infections

NCT ID: NCT00856323

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00115609

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00234910

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

When to Start HIV Treatment in Previously Untreated HIV/TB Coinfected Individuals

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01300481

Fosamprenavir Versus Other Protease Inhibitors

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00094523

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Condition: HIV; HIV Infections

NCT ID: NCT00358696

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy Instead of a Triple Therapy That Includes Lopinavir/Ritonavir and Lamivudine or Emtricitabine in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

Directly Administered HIV Therapy in Methadone Clinics

Condition: HIV Infections; Heroin Dependence

NCT ID: NCT00279110

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

Condition: HIV Infections

NCT ID: NCT00660972

Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies

Condition: HIV Infection

NCT ID: NCT01152918

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Condition: HIV Infections; HIV-1; Human Immunodeficiency Virus Type 1

NCT ID: NCT00540449

Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples

Condition: HIV-1 Infections; HIV Infections

NCT ID: NCT00557245

Comparison of HIV Clinic-Based Treatment With Buprenorphine Versus Referred Care in Heroin-Dependent Participants

Condition: Opiate Dependence; HIV Seropositivity; HIV Infections

NCT ID: NCT00130819

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Condition: HIV Infection; Herpes Simplex, Genital; Sexually Transmitted Diseases

NCT ID: NCT00194519

Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women

Condition: HIV Infections

NCT ID: NCT00705679

Psychosocial Needs of YMSM

Condition: HIV+ YMSM

NCT ID: NCT00710671

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Condition: HIV Infections; HIV-1

NCT ID: NCT00543725

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00150098

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China

Condition: HIV Infections

NCT ID: NCT00100594

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Condition: HIV Infections

NCT ID: NCT00326963

Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth

Condition: HIV Infection

NCT ID: NCT00103532

Pharmacotherapy for HIV Infected Patients With Alcohol Problems

Condition: HIV Infection; Heavy Alcoholic Consumption; HIV Infections

NCT ID: NCT00854230

Withdrawn

Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis

Condition: HIV-1 Infection

NCT ID: NCT01427738

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00120510

Micronutrients and Antioxidants in HIV Infection

Condition: HIV Infection

NCT ID: NCT00798772

Comparing the Safety and Efficacy of Topical Gentian Violet Versus Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-Infected People in Countries Outside of the United States

Condition: HIV Infections

NCT ID: NCT01494129

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122551

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Condition: HIV-Associated Lipodystrophy; HIV Infections

NCT ID: NCT00126308

A Long-term Follow-up of the HIV-NAT Cohort

Condition: HIV Infections

NCT ID: NCT00411983

SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada

Condition: HIV-1 Infection

NCT ID: NCT00323687

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Condition: HIV Infections

NCT ID: NCT00421551

Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya

Condition: HIV Infections

NCT ID: NCT00931216

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Condition: HIV Infections

NCT ID: NCT00196625

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Condition: HIV Infections; AIDS

NCT ID: NCT00122538

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla

Condition: HIV Infections

NCT ID: NCT00615745

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

Condition: HIV Infection

NCT ID: NCT00131677

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

Condition: HIV Infections

NCT ID: NCT00625404

Comparative Study of Three NNRTI-Sparing HAART Regimens

Condition: HIV Infection

NCT ID: NCT00811954

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01494038

Tuberculosis Prevention for HIV Infected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00057122

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00549198

Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda

Condition: HIV Infections

NCT ID: NCT00674921

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Condition: HIV Infections

NCT ID: NCT00447902

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Condition: HIV Infections

NCT ID: NCT00440271

Optimizing Treatment for Treatment-Experienced, HIV-infected People

Condition: HIV Infections

NCT ID: NCT00537394

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status

Condition: HIV Infections

NCT ID: NCT01040091

Early HIV Therapy in Patients With High CD4 Cell Counts

Condition: HIV

NCT ID: NCT01479634

Examining Benefits of HAART Continuation in Postpartum Mothers

Condition: HIV Infections

NCT ID: NCT00955968

Attitudes and Beliefs and the Steps of HIV Care

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00749840

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1

Condition: HIV Infection

NCT ID: NCT01576731

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00119769

Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants

Condition: HIV Infections

NCT ID: NCT00386035

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00226434

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

Condition: HIV Infections

NCT ID: NCT00552240

Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults

Condition: HIV-1 Infections

NCT ID: NCT00830804

TMC278-TiDP38-C213 (PAINT): An Open Label Trial to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Efficacy of TMC278 in Antiretroviral Naive HIV-1 Infected Adolescents

Condition: HIV Infections; HIV-1

NCT ID: NCT00799864

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1

Condition: HIV Infection

NCT ID: NCT01533272

HIV-HBV Co-Infection and Liver Disease

Condition: HIV Infections; HIV-HBV Co-Infection

NCT ID: NCT00637429

The RISAP-study: a Complex Intervention in Risk Communication and Shared Decision-making in General Practice

Condition: Prevention; Cardiovascular Disease; Decision Making; Decision Aids

NCT ID: NCT01187056

A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00398996

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01337570

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01337583

Raltegravir Switch for Toxicity or Adverse Events

Condition: HIV/AIDS; Antiretroviral Therapy; HIV Infections

NCT ID: NCT00958100

"The Once A Day Protease Inhibitor Regimens"

Condition: HIV Infections; Antiretroviral Therapy

NCT ID: NCT00242216

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00017719

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Condition: HIV Infection

NCT ID: NCT00326716

A Safety Study of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01071174

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Condition: HIV Infections; AIDS

NCT ID: NCT00302822

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Condition: HIV Infections

NCT ID: NCT00001137

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Condition: HIV Infections

NCT ID: NCT00335686

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Condition: HIV Infections

NCT ID: NCT00356616

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00089583

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00068809

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Condition: HIV Infections

NCT ID: NCT00255840

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Condition: HIV Infections

NCT ID: NCT00122512

Mentor Mothers: A Sustainable Family Intervention in South African Townships

Condition: Human Immunodeficiency Virus; Acquired Immune Deficiency Syndrome; Tuberculosis

NCT ID: NCT00972699

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

Condition: HIV Infection

NCT ID: NCT00094367

Breastfeeding, Antiretroviral, and Nutrition Study

Condition: HIV Infections

NCT ID: NCT00164736

Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen

Condition: HIV Infections

NCT ID: NCT00135369

Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder

Condition: Attention Deficit Disorder With Hyperactivity

NCT ID: NCT00429221

Safety and Acceptability of a Vaginal Microbicide

Condition: HIV Infections; Hepatitis B, Chronic

NCT ID: NCT00111943

Study of Pharmacokinetics in HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00433979

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00476853

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Condition: HIV Infections; Herpes Genitalis

NCT ID: NCT00405821

Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours

Condition: HIV Infections

NCT ID: NCT00607958

Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences

Condition: HIV Infections

NCT ID: NCT00675766

Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda

Condition: HIV

NCT ID: NCT00339456

Safety and Effectiveness of World Health Organization Dosing Guidelines of Lopinavir/Ritonavir for Children

Condition: HIV

NCT ID: NCT01172535

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT00449436

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

Condition: HIV Infections

NCT ID: NCT00357552

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Condition: HIV Infections

NCT ID: NCT00135395

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Condition: HIV Infections

NCT ID: NCT00318123

Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in India

Condition: HIV-1

NCT ID: NCT00341796

Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru

Condition: HIV; AIDS; HIV Infections

NCT ID: NCT01070017

Randomized Controlled Trial of Stress Management Training in HIV

Condition: HIV Infections

NCT ID: NCT00436085

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

Condition: HIV Infections

NCT ID: NCT00379405

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

Condition: HIV Infections; AIDS

NCT ID: NCT00301561

The Use of Leukapheresis to Support HIV Pathogenesis Studies

Condition: HIV

NCT ID: NCT01161199

Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India

Condition: HIV Infections; Heroin Dependence

NCT ID: NCT00709007

Withdrawn

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study

Condition: HIV Infections

NCT ID: NCT00192608

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

Condition: HIV Infections

NCT ID: NCT00414635

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Condition: HIV Infection

NCT ID: NCT00234923

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00297076

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Condition: HIV Infections

NCT ID: NCT00762320

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00197145

Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM

Condition: HIV

NCT ID: NCT01457066

Pediatric Nevirapine Resistance Study

Condition: AIDS; HIV Infections

NCT ID: NCT00117728

Atazanavir and Lamivudine for Treatment Simplification

Condition: HIV Infections

NCT ID: NCT00885482

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

Condition: HIV

NCT ID: NCT01581853

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

Condition: HIV; Hepatitis C

NCT ID: NCT01225705

Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

Condition: HIV Infections

NCT ID: NCT01363037

Switch to Darunavir/r + Maraviroc QD in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

Condition: HIV Infection

NCT ID: NCT01367210

NNRTI/PI Toxicity Switch to Darunavir Study

Condition: HIV

NCT ID: NCT00765154

Evaluation of Atazanavir Substitution Intervention (EASI) Study

Condition: HIV Infections

NCT ID: NCT00247845

Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS

Condition: HIV-1 Infection

NCT ID: NCT01435018

Atazanavir/Ritonavir Maintenance Therapy

Condition: HIV Infections

NCT ID: NCT00084019

Trial of Citalopram for the Prevention of Depression

Condition: Depression; HIV Infections; Hepatitis C

NCT ID: NCT00317746

Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle

Condition: AIDS

NCT ID: NCT01289444

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily

Condition: HIV Infections

NCT ID: NCT00314626

Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment

Condition: HIV Infections

NCT ID: NCT00751153

Tenofovir Gel in Pregnancy and Lactation

Condition: HIV Infections

NCT ID: NCT01136759

Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.

Condition: HIV

NCT ID: NCT00139087

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Condition: HIV

NCT ID: NCT01255371

Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

Condition: HIV Infections

NCT ID: NCT00312169

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Condition: HIV Infections

NCT ID: NCT00931463

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Condition: HIV Infections

NCT ID: NCT00709111

Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

Condition: HIV Infections

NCT ID: NCT00611039

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

Condition: HIV Infections

NCT ID: NCT00192634

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Condition: HIV Infections

NCT ID: NCT00000882

Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor

Condition: HIV Infection

NCT ID: NCT01166477

Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV

Condition: Tobacco Use Cessation; Tobacco Cessation; Tobacco Use Disorder; Tobacco Dependence; Tobacco-Use Disorder; Virus, Human Immunodeficiency

NCT ID: NCT01570595

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Condition: HIV Infections

NCT ID: NCT00160849

Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS

Condition: HIV Prevention; STD Prevention

NCT ID: NCT00267436

A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01597648

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Condition: Alcohol Abuse

NCT ID: NCT00371969

Microbicide Safety and Acceptability in Young Men

Condition: High Risk MSM; HIV Negative; 18-30 Years of Age

NCT ID: NCT01283360

Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01448915

HIV Risk Reduction and Drug Abuse Treatment in Iran

Condition: Opiate Dependence; HIV Infections

NCT ID: NCT00398008

Psychiatric Problems in Children and Adolescents Infected With HIV at Birth

Condition: HIV Infections; Mental Disorders

NCT ID: NCT00100542

Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples

Condition: HIV Infections; Sexually Transmitted Disease

NCT ID: NCT00644163

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Condition: Liver Diseases, Alcoholic; Alcoholism; HIV; Hepatitis C

NCT ID: NCT01410123

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Condition: AIDS

NCT ID: NCT00207168

Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution

Condition: Substance-related Disorders; HIV Risk Behavior

NCT ID: NCT01560221

Reducing High Risk Behavior in Drug Court

Condition: Substance Abuse; HIV

NCT ID: NCT01481428

Design and Evaluate 12 Week Group Therapy Intervention for HIV+ Methamphetamine Users and Deliver It Within an HIV/AIDS Primary Care Setting. - 1

Condition: Behavior Therapy; Methamphetamine

NCT ID: NCT00249678

Comparison of Facility and Home-Based ART Delivery Systems in Uganda

Condition: AIDS

NCT ID: NCT00144365

Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)

Condition: Medication Adherence

NCT ID: NCT01359280

Adherence, Improvement Measure (AIM) System

Condition: Patient Compliance; AIDS

NCT ID: NCT01252212

Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection

Condition: Cryptococcal Infection Disseminated

NCT ID: NCT01562132

62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides

Condition: Sexually Transmitted Infections

NCT ID: NCT00469547